Fate Therapeutics Inc. buy EF Hutton Acquisition Co. I
Start price
01.03.23
/
50%
€5.72
Target price
01.03.24
€9.37
Performance (%)
26.81%
End price
02.03.24
€7.25
Summary
This prediction ended on 02.03.24 with a price of €7.25. The prediction had a final performance of 26.81%. EF_Hutton_Acquisitio has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Fate Therapeutics Inc. | 16.840% | 16.840% | -16.044% |
| iShares Core DAX® | 1.432% | 2.628% | 12.457% |
| iShares Nasdaq 100 | 1.892% | -0.458% | 1.248% |
| iShares Nikkei 225® | -1.619% | 11.097% | 27.382% |
| iShares S&P 500 | 1.921% | 1.159% | 1.635% |
Comments by EF_Hutton_Acquisitio for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its "buy" rating re-affirmed by analysts at EF Hutton Acquisition Co. I. They now have a $10.00 price target on the stock.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von EF_Hutton_Acquisitio gewählte maximale Laufzeit wurde überschritten